Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorcros Regulatory News (NXR)

Share Price Information for Norcros (NXR)

Share Price is delayed by 15 minutes
Get Live Data
277.00    -12.00 (-4.15%)
Bid:
275.00
Ask:
279.00
Spread: 4.00 (1.455%)
Market Cap: £248.99m
NXR Live PriceLast checked at - London Stock Exchange

Intraday Norcros Share Chart

Interim Management Statement

10 Feb 2011 07:00

RNS Number : 9780A
Norcros PLC
10 February 2011
Β 

ο»Ώ

Norcros PLC

("Norcros", the "Group" or the "Company")

Β 

Interim Management Statement

Β 

Norcros, the home consumer products group, publishes its Interim Management Statement and this includes financial information covering the 17 week period to 30 January 2011.

Β 

The Group has maintained the strong trading performance reported in our interim statement in November 2010. Our UK businesses have continued to make significant progress despite the disruption caused by the extreme weather in December and the ongoing uncertainty over the impact of the tax increases and public sector cuts on consumer and business confidence. In South Africa the turnaround achieved at the interim stage has been sustained.

Β 

Group revenues for the comparable like-for-like period increased by 15.8% and by 10.2% on a constant currency basis relative to last year. This revenue growth reflects an increase of 10.9% in our UK operations and, on a constant currency basis, increases of 7.8% and 21.4% in our South African and Rest of the World operations respectively.

Β 

Β 

UK

Β 

Our UK businesses have maintained their strong performance and have continued to gain market share.

Β 

Triton, the UK market leader in domestic showers, increased UK revenues by 4.2%, with the majority of this growth being derived from the retail sector where further new product listings and our excellent customer service continued to drive outperformance. Export revenues, representing c16% of Triton's total revenues, were maintained in line with last year despite the ongoing economic problems in Ireland, our largest export market. As a result, Triton's total revenues were 3.5% higher.

Β 

Johnson Tiles, a leading UK manufacturer and supplier of ceramic tiles, continued to trade strongly and outperform the market with total revenues in the period ahead by 16.7%. Significantly higher retail revenues resulted in total UK revenues being 26.0% ahead of the equivalent period last year reflecting the success of new product ranges and additional business secured following the administration of a former UK competitor. Export revenues, representing c13% of Johnson Tiles' total revenues, were 22.6% lower reflecting both product availability issues and the timing of project completions. The commissioning of the additional kiln and inkjet capacity announced last year remains on track and is expected to be operational early in the next financial year.

Β 

Revenues in our UK adhesives business were 50% higher driven by new account gains in both trade and retail segments.

Β 

Β 

South Africa

Β 

Overall revenues were 21.2% ahead on a Sterling reported basis and 7.8% higher in constant currency despite the continuing low levels of building activity.

Β 

Revenues at our retail operation, Tile Africa, increased by 6.1% in constant currency as our retail sector maintained the strong performance reported earlier in the year (like for like retail revenues increased by 10.9%). In Johnson Tiles, our tile manufacturing operation, constant currency revenues increased by 29.4% as further progress was made to increase sales to the independent sector and to drive growth in contiguous export markets. TAL, our adhesive operation increased revenues by 5.8% reflecting the strength of our product offer and technical service support.

Β 

Β 

Outlook

Β 

Management remains focused on driving market share gains in our UK operations and securing additional operational improvements in our South African businesses. The Board believes that, as a result of the investment in new product development, operational improvements and sales and marketing initiatives, combined with the strength of the Group's leading market positions, Norcros is well positioned to make further progress.

Β 

Β 

10 February 2011

Β 

Β 

ENQUIRIES:

Β 

Norcros plc

Tel: 01625 547700

Joe Matthews, Group Chief Executive

Nick Kelsall, Group Chief Executive - Designate

College Hill

Tel: 020 7457 2020

Mark Garraway

Adam Aljewicz

Β 

For further information please visit the Company website: www.norcros.com

Β 

Β 

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IMSEAXANEFNFEFF
Date   Source Headline
22nd Jul 20244:06 pmRNSDirector Dealings - APSP Share Option exercises
19th Jul 202410:36 amRNSTotal Voting Rights
2nd Jul 20241:51 pmRNSHolding(s) in Company
1st Jul 202412:53 pmRNSTotal Voting Rights
1st Jul 20247:00 amRNSDirector Declaration
21st Jun 20247:00 amRNSAnnual Financial Report and Notice of 2024 AGM
18th Jun 20243:50 pmRNSDirector/PDMR Shareholding
13th Jun 20247:00 amRNSResults for the year ended 31 March 2024
31st May 20247:00 amRNSTotal Voting Rights
30th May 20244:15 pmRNSHolding(s) in Company
24th May 20247:00 amRNSAppointment of Independent Non-Executive Director
23rd May 20247:30 amRNSDirector Declaration
20th May 20247:00 amRNSSale of Johnson Tiles UK
7th May 20247:00 amRNSNorcros business wins King's Award for Enterprise
1st May 202410:52 amRNSVoting Rights and Share Capital Update
1st May 20247:00 amRNSCapital Markets Event
25th Apr 20247:00 amRNSSale of Johnson Tiles UK
22nd Apr 20242:00 pmRNSInvestor Webinar 7 May 2024
12th Apr 20243:40 pmRNSHolding(s) in Company
11th Apr 20247:00 amRNSTrading update
28th Mar 20247:00 amRNSBlock listing Six Monthly Return
28th Mar 20247:00 amRNSVoting Rights and Share Capital Update
1st Mar 20242:09 pmRNSDirectors Share Dealing
23rd Jan 202411:40 amRNSHolding(s) in Company
23rd Jan 20247:00 amRNSAppointment of Joint Corporate Broker
22nd Dec 20237:00 amRNSEmployee SAYE awards and director share dealing
1st Dec 20234:35 pmRNSDirector Declaration
23rd Nov 20234:06 pmRNSDirector/PDMR Shareholding
16th Nov 20237:00 amRNSInterim Results
3rd Nov 20239:00 amRNSInvestor Presentation
12th Oct 20237:00 amRNSTrading Update
1st Sep 20237:00 amRNSBlock Listing Six Monthly Return
11th Aug 20234:36 pmRNSDirector's Dealings
26th Jul 20234:50 pmRNSResults of AGM
26th Jul 20231:06 pmRNSDirector's Dealings
26th Jul 20237:00 amRNSAGM Trading Statement
10th Jul 20235:59 pmRNSDirector's Dealings
23rd Jun 20237:00 amRNSAnnual Financial Report and Notice of 2023 AGM
15th Jun 20237:00 amRNSFinal Results
30th May 20237:00 amRNSDirectorate Changes
13th Apr 20237:00 amRNSTrading Update
31st Mar 20237:00 amRNSTotal Voting Rights
28th Mar 20234:16 pmRNSHolding(s) in Company
21st Mar 20234:35 pmRNSPrice Monitoring Extension
28th Feb 20233:19 pmRNSBlock Listing Six Monthly Return
14th Feb 20237:00 amRNSDirectorate Update
30th Jan 20237:00 amRNSCEO Succession
24th Jan 20237:00 amRNSDirectorate Update
15th Dec 20229:40 amRNSBoard Changes
9th Nov 20227:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.